Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-01 |
2024-03 |
0.46 |
0.48 |
0.02 |
4.35% |
2024-02-01 |
2023-12 |
0.42 |
0.4 |
-0.02 |
-4.76% |
2023-10-31 |
2023-09 |
0.44 |
0.41 |
-0.03 |
-6.82% |
2023-08-08 |
2023-06 |
0.55 |
0.55 |
N/A |
N/A |
2023-05-03 |
2023-03 |
0.53 |
0.53 |
N/A |
N/A |
2023-02-02 |
2022-12 |
0.49 |
0.47 |
-0.02 |
-4.08% |
Date |
Firm |
Action |
From |
To |
2023-09-11 |
RBC Capital |
Upgrade |
Sector Perform |
Sector Perform |
2023-08-27 |
William Blair |
Upgrade |
|
Outperform |
2023-08-17 |
Benchmark |
Upgrade |
Buy |
Buy |
2023-08-08 |
Stephens & Co. |
Upgrade |
Overweight |
Overweight |
2023-05-03 |
RBC Capital |
Upgrade |
|
Sector Perform |
2023-05-03 |
Stephens & Co. |
Upgrade |
|
Overweight |
Date |
Name |
Relation |
Quantity |
Description |
2023-10-25 |
BAUMGARTNER ROBERT V |
Director |
43.40K |
Stock Award(Grant) |
2024-04-02 |
BOHNEN SHANE |
General Counsel |
1.65K |
Conversion of Exercise of derivative security |
2023-10-25 |
BUSHMAN JULIE L. |
Director |
5.67K |
Stock Award(Grant) |
2024-05-13 |
HIGGINS JOHN L |
Director |
36.61K |
Sale |
2023-12-18 |
HIPPEL JAMES |
Chief Financial Officer |
71.88K |
Conversion of Exercise of derivative security |
2023-10-25 |
KEEGAN JOSEPH D |
Director |
12.31K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
18.36M |
1.50B |
11.60% |
2023-06-29 |
Blackrock Inc. |
16.92M |
1.38B |
10.69% |
2023-06-29 |
State Street Corporation |
6.41M |
523.59M |
4.05% |
2023-06-29 |
BAMCO Inc. |
5.38M |
439.21M |
3.40% |
2023-06-29 |
Select Equity Group, Inc. |
4.51M |
368.48M |
2.85% |
2023-06-29 |
Price (T.Rowe) Associates Inc |
4.07M |
332.02M |
2.57% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
4.91M |
400.70M |
3.10% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
4.06M |
331.79M |
2.57% |
2023-06-29 |
Vanguard 500 Index Fund |
3.75M |
306.15M |
2.37% |
2023-06-29 |
Baron Growth Fund |
2.94M |
239.99M |
1.86% |
2023-05-30 |
Blackrock Funds-Mid-Cap Growth Equity Portfolio |
2.42M |
198.22M |
1.53% |
2023-06-29 |
Neuberger & Berman Genesis Fund |
2.37M |
193.07M |
1.49% |
Dividend |
Date |
0.08 |
2024-05-10 |
0.08 |
2024-02-09 |
0.08 |
2023-11-09 |
0.08 |
2023-08-17 |
0.08 |
2023-05-12 |
0.08 |
2023-02-10 |
Split |
Date |
4 : 1 |
2022-11-30 |
2 : 1 |
2000-12-04 |
2 : 1 |
1997-11-18 |